OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*
$121,880R01FY2007FDFDA
Cincinnati Childrens Hosp Med Ctr, Cincinnati OH
Investigators
Linked publications, trials & patents
Abstract
Abstract Not Provided
View original record on NIH RePORTER →